Renal Cell Carcinoma Stage III Clinical Trial
Official title:
Resection of Renal Cell Carcinoma and Stage IV Inferior Vena Cava Thrombus Without Thoracotomy: A Case Series and Literature Review.
Verified date | April 2020 |
Source | Attikon Hospital |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Observational |
Assessment of short-term outcomes of radical nephrectomy combined with IVC thrombectomy with a novel technique without thoracotomy: single center case series.
Status | Completed |
Enrollment | 3 |
Est. completion date | March 31, 2020 |
Est. primary completion date | March 31, 2020 |
Accepts healthy volunteers | No |
Gender | All |
Age group | 18 Years and older |
Eligibility |
Inclusion Criteria: - Adult patients - Documented radiological and/or pathological diagnosis of renal cell carcinoma with level IV tumor thrombus Exclusion Criteria: - American Anesthesia Association (ASA) Class V and/or any contraindications to general anesthesia |
Country | Name | City | State |
---|---|---|---|
Greece | Attikon University Hospital | Chaidari |
Lead Sponsor | Collaborator |
---|---|
Attikon Hospital |
Greece,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Short term mortality rate | Percentage of patients` postoperative deaths | 30 days | |
Secondary | Short term major complications` rate | Incidence of Clavien/Dindo grade 3 or more postoperative complications | 30 days | |
Secondary | Recurrence rate | Rate of local or systemic recurrence | 27 months |
Status | Clinical Trial | Phase | |
---|---|---|---|
Terminated |
NCT06377722 -
Cabozantinib Treatment Prior to Cytoreductive Nephrectomy in Patients With Advanced or Metastatic Renal Cells Cancer
|
Phase 2 |